SMAD2 and hepatocellular carcinoma: The levels of TGF-βR2, phosphorylated Smad2/3, and the genes associated with the TGF-β signaling pathway were significantly increased in hepatocellular carcinoma (HCC) lesions of TAK1ΔHEP mice compared with wild-type normal livers.